Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries
about
Recent developments in the diagnosis and management of tuberculosis.Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settingsLow implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection.Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana.A guide to aid the selection of diagnostic tests.Standardized radiographic interpretation of thoracic tuberculosis in children.Rapid Diagnosis of Tuberculosis from Analysis of Urine Volatile Organic Compounds.Has the utilisation of Xpert MTB/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis
P2860
Q28077124-7B1C06A0-246D-4B93-9ACA-9141B0A23636Q36228816-6482C7B2-BB34-4F3A-AC6E-98F0FB58FFD2Q36275494-1BE5B3C1-3CB1-49E8-9BA4-DE2A24D4BE1DQ37358635-E4FACBAD-38CB-407E-8C1D-69AC414649BAQ38914967-54293992-D54D-4682-9F12-E578CCADAF67Q40107565-C1F178C2-6A4B-4437-82B5-6AD3499266F4Q40487862-4656308D-414A-448F-BA71-E163C849598FQ41575780-4E042374-460F-435F-BA00-0E4C16C3C3A3Q42351166-98BB7194-D90D-44C2-83C2-101D4B5C9038Q46924650-40EAE003-486A-4EC0-BE58-C23AE5CE5866Q57071505-A708E727-BCFE-4F8F-9453-B5A064887B1EQ58791284-61347279-E7EE-4561-AD85-A9896A3E9275
P2860
Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@ast
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@en
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@nl
type
label
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@ast
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@en
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@nl
prefLabel
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@ast
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@en
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@nl
P2093
P2860
P1433
P1476
Implementing the Xpert® MTB/RI ...... essons Learned in 18 Countries
@en
P2093
Anne-Laure Page
Cara S Kosack
Elisa Ardizzoni
Emmanuel Fajardo
Francis Varaine
Martina Casenghi
Pamela Hepple
Peter Saranchuk
P2860
P304
P356
10.1371/JOURNAL.PONE.0144656
P407
P577
2015-01-01T00:00:00Z